BC
BRNS

Brookfield Corp’s Barinthus Biotherapeutics BRNS Stock Holding History

Brookfield Corp’s Portfolio BRNS Stock Details BRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,921
Closed -$251K – 621
2021
Q3 		$251K Sell
15,921
-9,079
-36% -$143K ﹤0.01% 478
2021
Q2 		$420K Buy
+25,000
New +$420K ﹤0.01% 495